1. Preface
1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. Key Offerings
1.2. Market Segmentation
1.3. Research Methodology
1.3.1. Phase I - Secondary Research
1.3.2. Phase II - Primary Research
1.3.3. Phase III - Expert Panel Review
1.3.4. Assumptions
1.3.5. Approach Adopted

2. Executive Summary
2.1. Market Snapshot: Global Thyroid Gland Disorders Treatment Market
2.2. Global Thyroid Gland Disorders Treatment Market, By Treatments, 2023 (US$ Million)
2.3. Global Thyroid Gland Disorders Treatment Market, By Geography, 2023 (US$ Million)
2.4. Attractive Investment Proposition by Geography, 2023

3. Thyroid Gland Disorders Treatment Market: Competitive Analysis
3.1. Market Positioning of Key Thyroid Gland Disorders Treatment Market Vendors
3.2. Strategies Adopted by Thyroid Gland Disorders Treatment Market Vendors
3.3. Key Industry Strategies
4. Thyroid Gland Disorders Treatment Market: Macro Analysis & Market Dynamics
4.1. Introduction
4.2. Global Thyroid Gland Disorders Treatment Market Value, 2022 - 2032, (US$ Million)
4.3. Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Key Challenges
4.3.4. Key Opportunities
4.4. Impact Analysis of Drivers and Restraints
4.5. See-Saw Analysis
4.6. Porter's Five Force Model
4.6.1. Supplier Power
4.6.2. Buyer Power
4.6.3. Threat Of Substitutes
4.6.4. Threat Of New Entrants
4.6.5. Competitive Rivalry
4.7. PESTEL Analysis
4.7.1. Political Landscape
4.7.2. Economic Landscape
4.7.3. Technology Landscape
4.7.4. Legal Landscape
4.7.5. Social Landscape

5. Thyroid Gland Disorders Treatment Market: By Treatments, 2022-2032, USD (Million)
5.1. Market Overview
5.2. Growth & Revenue Analysis: 2023 Versus 2032
5.3. Market Segmentation
5.3.1. Hypothyroidism
5.3.1.1. Levothyroxine
5.3.1.2. Liothyronine
5.3.2. Hyperthyroidism
5.3.2.1. Imidazole
5.3.2.2. Propacil


6. North America Thyroid Gland Disorders Treatment Market, 2022-2032, USD (Million)
6.1. Market Overview
6.2. Thyroid Gland Disorders Treatment Market: By Treatments, 2022-2032, USD (Million)
6.3.Thyroid Gland Disorders Treatment Market: By Region, 2022-2032, USD (Million)
6.3.1.North America
6.3.1.1. U.S.
6.3.1.1.1. Thyroid Gland Disorders Treatment Market: By Treatments, 2022-2032, USD (Million)
6.3.1.2. Canada
6.3.1.2.1. Thyroid Gland Disorders Treatment Market: By Treatments, 2022-2032, USD (Million)
6.3.1.3. Rest of North America
6.3.1.3.1. Thyroid Gland Disorders Treatment Market: By Treatments, 2022-2032, USD (Million)

7. UK and European Union Thyroid Gland Disorders Treatment Market, 2022-2032, USD (Million)
7.1. Market Overview
7.2. Thyroid Gland Disorders Treatment Market: By Treatments, 2022-2032, USD (Million)
7.3.Thyroid Gland Disorders Treatment Market: By Region, 2022-2032, USD (Million)
7.3.1.UK and European Union
7.3.1.1. UK
7.3.1.1.1. Thyroid Gland Disorders Treatment Market: By Treatments, 2022-2032, USD (Million)
7.3.1.2. Germany
7.3.1.2.1. Thyroid Gland Disorders Treatment Market: By Treatments, 2022-2032, USD (Million)
7.3.1.3. Spain
7.3.1.3.1. Thyroid Gland Disorders Treatment Market: By Treatments, 2022-2032, USD (Million)
7.3.1.4. Italy
7.3.1.4.1. Thyroid Gland Disorders Treatment Market: By Treatments, 2022-2032, USD (Million)
7.3.1.5. France
7.3.1.5.1. Thyroid Gland Disorders Treatment Market: By Treatments, 2022-2032, USD (Million)
7.3.1.6. Rest of Europe
7.3.1.6.1. Thyroid Gland Disorders Treatment Market: By Treatments, 2022-2032, USD (Million)

8. Asia Pacific Thyroid Gland Disorders Treatment Market, 2022-2032, USD (Million)
8.1. Market Overview
8.2. Thyroid Gland Disorders Treatment Market: By Treatments, 2022-2032, USD (Million)
8.3.Thyroid Gland Disorders Treatment Market: By Region, 2022-2032, USD (Million)
8.3.1.Asia Pacific
8.3.1.1. China
8.3.1.1.1. Thyroid Gland Disorders Treatment Market: By Treatments, 2022-2032, USD (Million)
8.3.1.2. Japan
8.3.1.2.1. Thyroid Gland Disorders Treatment Market: By Treatments, 2022-2032, USD (Million)
8.3.1.3. India
8.3.1.3.1. Thyroid Gland Disorders Treatment Market: By Treatments, 2022-2032, USD (Million)
8.3.1.4. Australia
8.3.1.4.1. Thyroid Gland Disorders Treatment Market: By Treatments, 2022-2032, USD (Million)
8.3.1.5. South Korea
8.3.1.5.1. Thyroid Gland Disorders Treatment Market: By Treatments, 2022-2032, USD (Million)
8.3.1.6. Rest of Asia Pacific
8.3.1.6.1. Thyroid Gland Disorders Treatment Market: By Treatments, 2022-2032, USD (Million)

9. Latin America Thyroid Gland Disorders Treatment Market, 2022-2032, USD (Million)
9.1. Market Overview
9.2. Thyroid Gland Disorders Treatment Market: By Treatments, 2022-2032, USD (Million)
9.3.Thyroid Gland Disorders Treatment Market: By Region, 2022-2032, USD (Million)
9.3.1.Latin America
9.3.1.1. Brazil
9.3.1.1.1. Thyroid Gland Disorders Treatment Market: By Treatments, 2022-2032, USD (Million)
9.3.1.2. Mexico
9.3.1.2.1. Thyroid Gland Disorders Treatment Market: By Treatments, 2022-2032, USD (Million)
9.3.1.3. Rest of Latin America
9.3.1.3.1. Thyroid Gland Disorders Treatment Market: By Treatments, 2022-2032, USD (Million)

10. Middle East and Africa Thyroid Gland Disorders Treatment Market, 2022-2032, USD (Million)
10.1. Market Overview
10.2. Thyroid Gland Disorders Treatment Market: By Treatments, 2022-2032, USD (Million)
10.3.Thyroid Gland Disorders Treatment Market: By Region, 2022-2032, USD (Million)
10.3.1.Middle East and Africa
10.3.1.1. GCC
10.3.1.1.1. Thyroid Gland Disorders Treatment Market: By Treatments, 2022-2032, USD (Million)
10.3.1.2. Africa
10.3.1.2.1. Thyroid Gland Disorders Treatment Market: By Treatments, 2022-2032, USD (Million)
10.3.1.3. Rest of Middle East and Africa
10.3.1.3.1. Thyroid Gland Disorders Treatment Market: By Treatments, 2022-2032, USD (Million)

11. Company Profile
11.1. Abbott Laboratories
11.1.1. Company Overview
11.1.2. Financial Performance
11.1.3. Product Portfolio
11.1.4. Strategic Initiatives
11.2. Abbvie, Inc.
11.2.1. Company Overview
11.2.2. Financial Performance
11.2.3. Product Portfolio
11.2.4. Strategic Initiatives
11.3. Allergan plc.
11.3.1. Company Overview
11.3.2. Financial Performance
11.3.3. Product Portfolio
11.3.4. Strategic Initiatives
11.4. GlaxoSmithKline plc
11.4.1. Company Overview
11.4.2. Financial Performance
11.4.3. Product Portfolio
11.4.4. Strategic Initiatives
11.5. Merck KGaA
11.5.1. Company Overview
11.5.2. Financial Performance
11.5.3. Product Portfolio
11.5.4. Strategic Initiatives
11.6. Mylan N.V.
11.6.1. Company Overview
11.6.2. Financial Performance
11.6.3. Product Portfolio
11.6.4. Strategic Initiatives
11.7. Novartis AG
11.7.1. Company Overview
11.7.2. Financial Performance
11.7.3. Product Portfolio
11.7.4. Strategic Initiatives
11.8. Lannett Company Inc.
11.8.1. Company Overview
11.8.2. Financial Performance
11.8.3. Product Portfolio
11.8.4. Strategic Initiatives
11.9. Sonofi
11.9.1. Company Overview
11.9.2. Financial Performance
11.9.3. Product Portfolio
11.9.4. Strategic Initiatives
11.10. Takeda Pharmaceutical Company Ltd
11.10.1. Company Overview
11.10.2. Financial Performance
11.10.3. Product Portfolio
11.10.4. Strategic Initiatives
11.11. Other Notable Players
11.11.1. Company Overview
11.11.2. Financial Performance
11.11.3. Product Portfolio
11.11.4. Strategic Initiatives